Covered recipient · General Payments record
SARAH M O'LEARY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$676.09
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $237.67 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $77.90 | 4 |
| Lilly USA, LLC | $60.05 | 3 |
| Novo Nordisk AS | $38.95 | 2 |
| GlaxoSmithKline, LLC. | $31.43 | 2 |
| PFIZER INC. | $15.64 | 1 |
| Acerta Pharma LLC | $13.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.25 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125200264 | CMS |
| Abbott Laboratories | $20.18 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125200266 | CMS |
| Abbott Laboratories | $16.11 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125200268 | CMS |
| Abbott Laboratories | $23.36 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125200270 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.70 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104221269 | CMS |
| GlaxoSmithKline, LLC. | $16.73 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116201833 | CMS |
| GlaxoSmithKline, LLC. | $14.70 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116635636 | CMS |
| Lilly USA, LLC | $16.69 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135377518 | CMS |
| Lilly USA, LLC | $29.78 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135416045 | CMS |
| Lilly USA, LLC | $13.58 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135395301 | CMS |
| Novo Nordisk Inc | $19.59 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097125994 | CMS |
| Novo Nordisk Inc | $19.36 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096823493 | CMS |
| PFIZER INC. | $15.64 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130959113 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.